CG Results Healthcare has advised MSD on the divestment of its Mirabel manufacturing site in Riom France, to Fareva

CG Results Healthcare is delighted to have acted as the exclusive advisor to MSD, a leading global biopharmaceutical company, on the divestment of its Mirabel manufacturing site located in Riom France, to Fareva, one of the world’s leading CDMOs in the pharmaceuticals sector.

The transaction includes the transfer of approximately 350 employees to Fareva and substantial future investment into the site. Fareva expects this investment will enable long-term growth and potential job creation at the site.

This cross-border transaction highlights CG Results Healthcare’s excellent reputation in the healthcare and life sciences sector and is a testament to its international network.